Navigation Links
Macrophage Differentiation Kit from 3H Biomedical AB

ProductsMacrophage Differentiation Kit from 3H Biomedical AB
Company 3H Biomedical AB
Item Macrophage Differentiation Kit
Price $149.00
Description Complete cell culture media with cytokines
Info 3H Biomedical AB3H Biomedical AB
Dag Hammarskjlds vg 34,
House Generalen, Uppsala Science Park
751 83 Uppsala
Sweden
Customer Service: (+46) 018-504400
Web Site: http://www.3hbiomedical.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Human Granulocyte Macrophage Colony Stimulating Factor, Unconjugated from PeproTech
2. Mouse Anti-Macrophage L1 protein Calprotectin Monoclonal Antibody, Unconjugated, Clone B314.1 (MAC 387) from Abcam
3. Rat Anti-Mouse Macrophages (metallophillic) Monoclonal Antibody, Unconjugated, Clone MOMA-1 from CEDARLANE Laboratories Limited
4. Rabbit Anti-Mouse MIP-1g (Macrophage InflammatoryProtein-1 gamma, CCL9, CCL10) Antibody, Biotin Conjugated from CEDARLANE Laboratories Limited
5. Rat Anti-Mouse Macrophages, Metallophilic Monoclonal Antibody, Unconjugated from AbD Serotec
6. Rabbit Anti-Human Macrophage-stimulating protein receptor Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
7. Mouse Dopaminergic Neuron Differentiation Kit, 2nd Generation from R&D Systems
8. BD Hepatocyte Differentiation Environment from BD Biosciences - Discovery Labware
9. BD Intestinal Epithelium Differentiation Environment from BD Biosciences - Discovery Labware
10. MoDC Differentiation Kit from 3H Biomedical AB
11. Mouse Oligodendrocyte Differentiation Kit from R&D Systems
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Munich lab demonstrates diesel truck engine with barely measurable emissions 2Munich lab demonstrates diesel truck engine with barely measurable emissions 3HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 1HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 2Humanitas Designated as Approved Provider by California Board of Registered Nursing for Continuing Education Course Credit and Units 52948 1Humanitas Designated as Approved Provider by California Board of Registered Nursing for Continuing Education Course Credit and Units 52948 2Humanitas Designated as Approved Provider by California Board of Registered Nursing for Continuing Education Course Credit and Units 52948 3TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 52945 1TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 52945 2TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 52945 3TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 52945 4
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3